FI840069A - Resinat av en substituerad karboxylsyra, foerfarande foer dess framstaellning, dess anvaendning och detta innehaollande farmaceutiska preparat. - Google Patents

Resinat av en substituerad karboxylsyra, foerfarande foer dess framstaellning, dess anvaendning och detta innehaollande farmaceutiska preparat. Download PDF

Info

Publication number
FI840069A
FI840069A FI840069A FI840069A FI840069A FI 840069 A FI840069 A FI 840069A FI 840069 A FI840069 A FI 840069A FI 840069 A FI840069 A FI 840069A FI 840069 A FI840069 A FI 840069A
Authority
FI
Finland
Prior art keywords
dess
karboxylsyra
resinat
substituerad
detta
Prior art date
Application number
FI840069A
Other languages
English (en)
Other versions
FI840069A0 (fi
FI82682C (fi
FI82682B (fi
Inventor
Satish Chandra Khanna
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI840069A0 publication Critical patent/FI840069A0/fi
Publication of FI840069A publication Critical patent/FI840069A/fi
Application granted granted Critical
Publication of FI82682B publication Critical patent/FI82682B/fi
Publication of FI82682C publication Critical patent/FI82682C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/44—Preparation of metal salts or ammonium salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI840069A 1983-01-12 1984-01-09 Foerfarande foer framstaellning av ett anti-inflammatoriskt och analgetiskt verksamt resinat av en substituerad karboxylsyra. FI82682C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH14783A CH655507B (fi) 1983-01-12 1983-01-12
CH14783 1983-01-12

Publications (4)

Publication Number Publication Date
FI840069A0 FI840069A0 (fi) 1984-01-09
FI840069A true FI840069A (fi) 1984-07-13
FI82682B FI82682B (fi) 1990-12-31
FI82682C FI82682C (fi) 1991-04-10

Family

ID=4180317

Family Applications (1)

Application Number Title Priority Date Filing Date
FI840069A FI82682C (fi) 1983-01-12 1984-01-09 Foerfarande foer framstaellning av ett anti-inflammatoriskt och analgetiskt verksamt resinat av en substituerad karboxylsyra.

Country Status (41)

Country Link
US (1) US4510128A (fi)
EP (1) EP0122219B1 (fi)
JP (1) JPS59134759A (fi)
KR (1) KR900006747B1 (fi)
AR (1) AR240310A1 (fi)
AT (2) AT391467B (fi)
AU (1) AU570230B2 (fi)
BE (1) BE898649A (fi)
CA (1) CA1218077A (fi)
CH (1) CH655507B (fi)
CS (1) CS269954B2 (fi)
DD (1) DD218373A5 (fi)
DE (2) DE3474152D1 (fi)
DK (1) DK166683B1 (fi)
DZ (1) DZ593A1 (fi)
EG (1) EG16562A (fi)
ES (1) ES528770A0 (fi)
FI (1) FI82682C (fi)
FR (1) FR2542735B1 (fi)
GB (1) GB2134529B (fi)
GR (1) GR79793B (fi)
HK (1) HK90390A (fi)
HU (1) HU190750B (fi)
IE (1) IE56545B1 (fi)
IL (1) IL70660A (fi)
IT (1) IT1177501B (fi)
LU (1) LU85171A1 (fi)
MA (1) MA20000A1 (fi)
MC (1) MC1564A1 (fi)
MT (1) MTP943B (fi)
NL (1) NL8400098A (fi)
NO (1) NO162862C (fi)
NZ (1) NZ206815A (fi)
OA (1) OA07628A (fi)
PH (1) PH21795A (fi)
PL (1) PL142737B1 (fi)
PT (1) PT77932B (fi)
RO (1) RO88481A (fi)
SE (1) SE457959B (fi)
ZA (1) ZA84212B (fi)
ZW (1) ZW484A1 (fi)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
ES8604955A1 (es) * 1985-11-08 1986-03-16 Covex Sa Procedimiento para la preparacion de resinatos de la (-) eburnamenina-14-(15h)-ona
US5230885A (en) * 1987-12-23 1993-07-27 Smith Kline & French Laboratories Limited Polystyrene anion exchange polymer pharmaceutical composition
AU608114B2 (en) * 1987-12-23 1991-03-21 Smith Kline & French Laboratories Limited Compounds
GB8730010D0 (en) * 1987-12-23 1988-02-03 Smith Kline French Lab Compounds
CH675537A5 (fi) * 1988-03-25 1990-10-15 Ciba Geigy Ag
SE509029C2 (sv) * 1988-08-16 1998-11-30 Ss Pharmaceutical Co Långtidsverkande diklofenak-natriumpreparat
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
EP0373103B1 (de) * 1988-11-10 1993-03-31 Ciba-Geigy Ag Flüssige orale Formulierung
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
GB8911719D0 (en) * 1989-05-22 1989-07-05 Smith Kline French Lab Compounds
GB8913699D0 (en) * 1989-06-14 1989-08-02 Smith Kline French Lab Compounds
GB8913700D0 (en) * 1989-06-14 1989-08-02 Smith Kline French Lab Compounds
US5079001A (en) * 1989-11-03 1992-01-07 Ciba-Geigy Corporation Liquid oral formulation of diclofenac
GB8928278D0 (en) * 1989-12-14 1990-02-21 Smith Kline French Lab Compounds
SE9004129D0 (sv) * 1990-12-21 1990-12-21 Pharmacia Lkb Biotech Anion exchanger
WO1993000873A1 (en) * 1991-07-03 1993-01-21 Sano Corporation Composition and method for transdermal delivery of diclofenac
US20020176842A1 (en) * 2001-04-09 2002-11-28 Lyn Hughes Extended release of active ingredients
DE60232290D1 (de) * 2001-04-09 2009-06-25 Rohm & Haas Kontrollierte Auflösung von Wirkstoffen
US20030180249A1 (en) * 2002-03-18 2003-09-25 Khanna Satish Chandra Dosage forms for hygroscopic active ingredients
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof
WO2006061700A2 (en) * 2004-12-06 2006-06-15 Themis Laboratories Private Limited Rapid disintegrating taste masked compositions and a process for its preparations
KR101495146B1 (ko) * 2006-03-16 2015-02-24 트리스 파마 인코포레이티드 약물 - 이온교환 수지 복합체를 함유하는 변형 방출 제제
US7799347B2 (en) 2006-09-07 2010-09-21 Chondrex Inc. Endotoxin-adsorbent for the prevention and treatment of autoimmune diseases
JP5670336B2 (ja) * 2008-10-02 2015-02-18 ユニヴァーシティ オヴ ピッツバーグ オヴ ザ コモンウェルス システム オヴ ハイアー エデュケーション 全身性炎症の治療のためのポリマー吸着剤の投与
MX2020011961A (es) 2010-03-24 2022-04-19 Jazz Pharmaceuticals Inc Formas de dosis de liberacion controlada para substancias de farmaco de alta dosis, solubles en agua e higroscopicas.
WO2014028610A1 (en) 2012-08-15 2014-02-20 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US20180263936A1 (en) 2017-03-17 2018-09-20 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
CA3115122A1 (en) 2018-11-19 2020-05-28 Jazz Pharmaceuticals Ireland Limited Alcohol-resistant drug formulations
CN113473980A (zh) 2019-03-01 2021-10-01 弗拉梅尔爱尔兰有限公司 在进食状态下具有改善的药代动力学的γ-羟基丁酸酯组合物
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB857193A (en) * 1957-03-14 1960-12-29 Clinical Products Ltd Resin-drug compounds
GB823000A (en) * 1957-10-03 1959-11-04 Clinical Products Ltd Resin-drug compounds
GB869149A (en) * 1958-09-16 1961-05-31 Clinical Products Ltd Liquid pharmaceutical compositions comprising compounds of ion exchange resins and therapeutic substances
US3316282A (en) * 1965-02-08 1967-04-25 Squibb & Sons Inc Anion exchange resin complex of a cycloborate ester of a steroid
FI49600C (fi) * 1967-12-20 1975-08-11 Ciba Geigy Ag Menetelmä substituoitujen fenyylietikkahappojen ja näiden suolojen val mistamiseksi.
CH519476A (de) * 1968-03-30 1972-02-29 Hoechst Ag Verfahren zur Herstellung von Salzen von Acylamino-alkylbenzolsulfonyl-harnstoffen mit Anionenaustauschern
US3926864A (en) * 1971-06-21 1975-12-16 Ionics Ion exchange membranes having a macroporous surface area
GB1423694A (en) * 1973-07-10 1976-02-04 Beecham Group Ltd Pharmaceutical compositions
US4058491A (en) * 1975-02-11 1977-11-15 Plastomedical Sciences, Inc. Cationic hydrogels based on heterocyclic N-vinyl monomers
FR2352547A1 (fr) * 1976-05-25 1977-12-23 Viridis Ets Nouvelle resine anionique a action hypocholesterolemiante, son procede de preparation et compositions therapeutiques la contenant
US4217421A (en) * 1977-06-27 1980-08-12 Rohm And Haas Company Anion exchange resins prepared from crosslinked polystyrenesulfonylchloride
US4380590A (en) * 1978-09-19 1983-04-19 Rohm And Haas Company Emulsion copolymer cation exchange resins
IT1106718B (it) * 1978-12-21 1985-11-18 Alfa Farmaceutici Spa Composizioni a base di resine anioniche salificate farmacologicamente attive
US4207399A (en) * 1979-03-14 1980-06-10 Rohm And Haas Company Methylquinoline high polymer based on quaternary ammonium polymers
US4302548A (en) * 1980-05-22 1981-11-24 Rohm And Haas Company Production of ion exchange resins, the resins so produced and ion exchange processes using them

Also Published As

Publication number Publication date
MTP943B (en) 1984-06-05
FI840069A0 (fi) 1984-01-09
DD218373A5 (de) 1985-02-06
ZW484A1 (en) 1984-08-08
AU570230B2 (en) 1988-03-10
AR240310A1 (es) 1990-03-30
ATA784A (de) 1990-04-15
GB8400251D0 (en) 1984-02-08
BE898649A (fr) 1984-07-11
FI82682C (fi) 1991-04-10
CS17884A2 (en) 1989-10-13
SE8400098L (sv) 1984-07-13
JPH0257058B2 (fi) 1990-12-03
NO162862B (no) 1989-11-20
IL70660A0 (en) 1984-04-30
MA20000A1 (fr) 1984-10-01
DE3474152D1 (en) 1988-10-27
PL142737B1 (en) 1987-11-30
GB2134529A (en) 1984-08-15
FR2542735B1 (fr) 1986-04-18
DK11884D0 (da) 1984-01-11
ES8504849A1 (es) 1985-05-01
NO162862C (no) 1990-02-28
MC1564A1 (fr) 1984-11-12
EP0122219A2 (de) 1984-10-17
IT8447527A0 (it) 1984-01-10
DK11884A (da) 1984-07-13
GR79793B (fi) 1984-10-31
NZ206815A (en) 1986-08-08
HU190750B (en) 1986-10-28
ATE37378T1 (de) 1988-10-15
PH21795A (en) 1988-02-29
EP0122219A3 (en) 1985-05-08
IL70660A (en) 1987-08-31
GB2134529B (en) 1986-09-24
OA07628A (fr) 1985-05-23
IE840049L (en) 1984-07-12
US4510128A (en) 1985-04-09
IE56545B1 (en) 1991-08-28
CS269954B2 (en) 1990-05-14
AT391467B (de) 1990-10-10
RO88481A (ro) 1986-01-30
HK90390A (en) 1990-11-09
EP0122219B1 (de) 1988-09-21
SE8400098D0 (sv) 1984-01-10
DZ593A1 (fr) 2004-09-13
PL245656A1 (en) 1985-01-02
NL8400098A (nl) 1984-08-01
ES528770A0 (es) 1985-05-01
CH655507B (fi) 1986-04-30
PT77932A (en) 1984-02-01
PT77932B (en) 1986-07-22
ZA84212B (en) 1984-08-29
EG16562A (en) 1991-12-30
AU2323084A (en) 1984-07-19
HUT34151A (en) 1985-02-28
DE3400491A1 (de) 1984-07-12
FI82682B (fi) 1990-12-31
IT1177501B (it) 1987-08-26
SE457959B (sv) 1989-02-13
KR840007562A (ko) 1984-12-08
KR900006747B1 (ko) 1990-09-20
NO840090L (no) 1984-07-13
JPS59134759A (ja) 1984-08-02
FR2542735A1 (fr) 1984-09-21
LU85171A1 (de) 1984-10-24
DK166683B1 (da) 1993-06-28
DE3400491C2 (fi) 1988-11-10
CA1218077A (en) 1987-02-17

Similar Documents

Publication Publication Date Title
FI840069A (fi) Resinat av en substituerad karboxylsyra, foerfarande foer dess framstaellning, dess anvaendning och detta innehaollande farmaceutiska preparat.
FI77939B (fi) Askorbatstoerningsfri komposition, anordning och foerfarande foer bestaemning av peroxidativt aktiva substanser.
FI843403A (fi) Blandarmatur foer blandning av tvao vaetskor, saerskilt kallt och varmt vatten.
FI841400A0 (fi) 20-spiroxaner och dess analoger, som innehaoller en oeppen ring e, foerfarande foer deras framstaellning samt dess dessa innehaollande farmaceutiska preparat.
FI860559A0 (fi) 11 -fenyl-gonaner, deras framstaellning och dessa innehaollande farmaceutiska preparat.
FI875608A0 (fi) Stabila preparat av ricintoxin-a-kedja och rta-immunokonjugat och selektionsfoerfarande foer finnande av deras stabilisatorer.
FI843342A0 (fi) Anordning foer traening av benmuskulatur, cirkulation och armmuskulatur.
FI830032L (fi) Foerfarande och anordning foer bestaemmande av en oenskad centrallinje foer cylinderlika kroppar, saosom traestockar.
FI874020A0 (fi) Tetrahydrokinolinderivat, foerfarande foer deras framstaellning, deras anvaendning och dessa innehaollande farmaceutiska preparat.
FI841475A0 (fi) Triazinderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI834663A (fi) Substituerade azabicycloalkaner, deras anvaendning, dessa foereningar innehaollande farmaceutiska preparat och foerfarande foer framstaellning av dessa foereningar.
FI841740A (fi) Aminolaogalkyl-penem-foereningar, foerfarande foer deras framstaellning, dessa foereningar innehaollande farmaceutiska preparat och anvaendning av de sistnaemnda.
FI853369L (fi) Ny -glukosidasinhibitor, foerfarande foer framstaellning av denna, anvaendning av denna och farmaceutiska preparat.
FI844919L (fi) Substituerade spiro-pyridinderivat, dessa innehaollande farmaceutiska blandningar och foerfarande foer framstaellning av saodana foereningar och blandningar.
FI841479A (fi) Fenylalaninhydroxilas- cdna- kloner, foerfarande foer framstaellning av dessa och anvaendning av dessa foer diagnostisering av fenylketonuri.
FI851221A0 (fi) Benzazepinderivat, dessa innehaollande farmaceutiska blandningar och foerfarande foer framstaellning av saodana foereningar och blandningar.
FI841245A (fi) Gonadoliberinderivat innehaollande en - aspartylgrupp, foerfarande foer deras framstaellning och farmaceutiska preparat innehaollande dessa.
FI840843A (fi) Plasmider, foerfarande foer framstaellning av dessa, mikroorganismer innehaollande dessa och foerfaranden foer odling av mikroorganismerna.
FI824170A0 (fi) Imidazobensodiazepiner, foerfarande foer deras framstaellning, dessa foereningar innehaollande farmaceutiska preparat och deras anvaendning
FI843973L (fi) Foerfarande foer oeverfoering, saerskilt foer registrering och aotergivning av faergtelevisionssignaler.
FI844884L (fi) Akryltelomerer innehaollande medelst ljus tvaerbindande sidokedjor, syntes daerav och anvaendning av dessa foer belaeggning av metaller.
FI854858A0 (fi) 1,4-dihydropyridinderivat, deras framstaellning och farmaceutiska preparat innehaollande desamma.
FI851993A0 (fi) Kollagengel, foerfarande foer dess framstaellning och filmprodukter tillverkade av gelet.
FI843676A0 (fi) 7 -acylamido-3-cefem-4- karboxylsyraestrar, foerfarande foer deras framstaellning, dessa foereningar innehaollande farmaceutiska preparat samt anvaendning av de sistnaemnda.
FI832908A (fi) Upphaengningsplatta foer spiralborrar, gaengtappar och liknande verktyg foer jonytbelaeggning av verktyg.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MA Patent expired

Owner name: NOVARTIS AG